EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan

Tokimasa Hida iD, Masashi Idogawa iD, Junji Kato iD, Yukiko Kiniwa iD, Kohei Horimoto, Sayuri Sato, Masahide Sawada, Shoichiro Tange iD, Masae Okura, Ryuhei Okuyama, Takashi Tokino, Hisashi Uhara

Cancer Medicine · 2024

DOI: 10.1002/cam4.70360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Tokimasa Hida und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Mutation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Maruho Takagi Dermatology Foundation, Osaka Medical Research Foundation for Intractable Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acral and mucosal melanomas are more prevalent in Asians than in Caucasians, unlike cutaneous melanomas, which are predominant in Caucasians. Recent studies have suggested that non‐Caucasian cutaneous melanomas responded less to immune checkpoint inhibitors, highlighting the need for genetic profiling across ethnicities. This study aimed to elucidate the genetic characteristics of Japanese melanomas, which is an under‐researched topic.

Methods

Single‐nucleotide variants, indels, and copy number alterations in 104 Japanese melanoma patients (37 cutaneous, 52 acral, and 15 mucosal) were analyzed using custom panel sequencing.

Results

Driver events were detected in 94% of the cases. Among cutaneous melanoma cases, 76% had BRAF mutations, and 8% had NRAS mutations. In acral melanoma, BRAF (9%), NRAS (17%), KRAS (8%), KIT (19%), and NF1 (7%) mutations were detected. Major driver mutations in mucosal melanoma were detected in NRAS, KRAS, NF1, PTEN, GNAQ, and KIT. The median tumor mutational burden across all melanoma types was 4.6 mutations/Mb, with no significant difference between the cutaneous and acral/mucosal types. Of the 21 patients with both primary and metastatic lesions, 11 showed distinct mutations in each. Potentially actionable mutations were detected in 58 patients in addition to BRAF V600E/K mutations in 31.

Conclusions

This study highlights distinct genetic abnormalities and actionable alterations in Japanese melanoma patients. This suggests a lower tumor mutational burden in East Asian cutaneous melanoma, which may affect the efficacy of immune checkpoint inhibitors. The heterogeneity of driver mutations across and within individuals highlights the need for personalized treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsMutationHumansMaleFemaleJapanMiddle AgedAgedAdultMucous MembraneAged, 80 and overDNA Copy Number VariationsGTP PhosphohydrolasesProto-Oncogene Proteins B-rafMembrane Proteins

Stichwörter der Autor:innen

DNA copy number variationimmune checkpoint inhibitormelanomamolecular targeted therapymutation

Substanzen

NRAS protein, humanGTP PhosphohydrolasesProto-Oncogene Proteins B-rafBRAF protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Dermatology, Shinshu University School of Medicine, Nagano, Japan.

ORCID-Profile: Tokimasa Hida, Masashi Idogawa, Junji Kato, Yukiko Kiniwa, Shoichiro Tange

Förderung

  • Japan Society for the Promotion of Science
  • Maruho Takagi Dermatology Foundation
  • Osaka Medical Research Foundation for Intractable Diseases
  • Suhara Memorial Foundation
  • ITO

Zitieren

APA

Hida, T., Idogawa, M., Kato, J., Kiniwa, Y., Horimoto, K., Sato, S., Sawada, M., Tange, S., Okura, M., Okuyama, R., Tokino, T., & Uhara, H. (2024). Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan. Cancer Medicine. https://doi.org/10.1002/cam4.70360

Vancouver

Hida T, Idogawa M, Kato J, Kiniwa Y, Horimoto K, Sato S, et al. Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan. Cancer Medicine. 2024. doi:10.1002/cam4.70360

BibTeX
@article{Hida2024,
  author = {Hida, Tokimasa and Idogawa, Masashi and Kato, Junji and Kiniwa, Yukiko and Horimoto, Kohei and Sato, Sayuri and Sawada, Masahide and Tange, Shoichiro and Okura, Masae and Okuyama, Ryuhei and Tokino, Takashi and Uhara, Hisashi},
  title = {Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70360}
}
Kostenlos starten →